A senior government official said there will be a negotiation on the price and availability after the vaccine is approved for use in India. This person pointed to the vaccine’s $20 price tag in the US and compared it with the $3-4 at which the AstraZeneca/Oxford vaccine being made locally by the Serum Institute of India will be available.
source https://www.hindustantimes.com/india-news/price-capacity-key-areas-as-pfizer-files-for-license-in-india/story-fPF2dcurb3NJ7kwZ2AcE4M.html
No comments:
Post a Comment